Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease

Journal of the National Medical Association

Volumn 99, Issue 11, 2007, Pages 1243-1247

  Koca, Ebru ^a   Haznedaroglu, Ibrahim C ^a   Uner, Aysegul ^a   Sayinalp, Nilgün ^a   Saglam, Arzu E ^a   Goker, Hakan ^a   Ozcebe, Osman I ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Hodgkin's lymphoma; Tumors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPHOMA; MACROPHAGE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCHOLINESTERASE; CASE-CONTROL STUDIES; CELL PROLIFERATION; DISEASE PROGRESSION; ENDOTHELIUM; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MACROPHAGES;

EID: 37049022388     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Haznedaroglu IC, Ozturk MA. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol. 2003;35:867-880.
2. Haznedaroglu IC, Tuncer S, Gursoy M. A local renin-angiotensin system in the bone marrow. Med Hypotheses. 1996;46:507-510.
3. Montgomery H, Humphries SE, Leung PS. Renin-angiotensin systems: the new frontier. Int J Biochem Cell Biol. 2003;35:758.
4. Strawn WB, Richmond RS, Ann TE, et al. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol. 2004;126:120-126.
5. Abali H, Haznedaroglu IC, Goker H, et al. Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences. Hematology. 2002;7:75-82.
6. Hajek D, Tomiska M, Krahulcova E, et al. I/D ACE gene polymorphism in survival of leukemia patients - hypothesis and pilot study. Med Hypotheses. 2003;61:80-85.
7. Beyazit Y, Aksu S, Haznedaroglu IC, et al. Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia. Blood. 2005;106:4567a.
8. Bernstein KE. Views of the renin-angiotensin system: brilling, mimsy, and slithy tove. Hypertension. 2006;47:509-514.
9. Hubert C, Savary K, Gase JM, et al. The hematopoietic system: a new niche for the renin-angiotensin system. Nat Clin Pract Cardiovasc Med. 2006;3:80-85.
10. Aksu S, Beyazit Y, Haznedaroglu IC, et al. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML. Leuk Lymphoma. 2006;47:891-896.
11. Danilov SM, Sadovnikova E, Scharenborg N, et al. Angiotensin-Converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp Hematol. 2003;31:1301-1309.
12. Marusic-Vrsalovic M, Dominis M, Jaksic B, et al. Angiotensin I-converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow. Br J Haematol. 2003;123:539-541.
13. Beyazit Y, Aksu S, Haznedaroglu IC, et al. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J Natl Med Assoc. 2007;99:57-63.
14. Levens JM, Gordon J, Gregory CD. Micro-environmental factors in the survival of human B-lymphoma cells. Cell Death Differ. 2000;7:59-69.
15. Ogden CA, Pound JD, Batth BK, et al. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma. J Immunol. 2005;174:3015-3023.
16. Lechleitner M, Gattringer C, Gastl G, et al. Macrophage infiltration in non-Hodgkin's lymphomas: a quantitative in situ study. Immunobiology. 1986;171:381-387.
17. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71-78.
18. Canioni D, Salles G, Mounier N, et al. The poor prognosis value of high intra-tumoral macrophages counts in follicular lymphoma patients requires selection of appropriate cut-off and can be circumvented by rituximab therapy. Blood. 2006;108:247a.
19. Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 2005;106:2169-2174.
20. Mazur G, Halon A, Wrobel T, et al. Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes. Rocz Akad.Med Bialymst. 2004;49 Suppl 1:73-75.
21. Hermann M, Niemitz C, Marafioti T, et al. Reduced phagocytosis of apoptotic cells in malignant lymphoma. Int J Cancer. 1998;75:675-679.
22. Yanagitani Y, Rakugi H, Okamura A, et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension. 1999;33:335-339.
23. Alvaro T, Lejeune M, Camacho FI, et al. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica. 2006;91:1605-1612.
24. Alvaro T, Lejeune M, Salvado MT, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol. 2006;24:5350-5357.
25. Rocken C, Rohl FW, Diebler E, et al. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1206-1212.
26. Menon J, Soto-Pantoja DR, Callahan MF, et al. Angiotensin-(1-7) Inhibits growth of human lung adenocarcinoma Xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007;67:2809-2815.